BIOMAT Database Logo BIOMAT Database Logo

Synthesis of 1-beta-L-arabinofuranosylcytosine, the enantiomer of cytosine arabinoside. 1971

R L Tolman, and R K Robins

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

R L Tolman, and R K Robins
Nucleic acids. 12. Synthesis of the L enantiomer of 1- -arabinofuranosylcytosine and of O 2 ,O 2' -anhydro-1- -D-arabinofuranosylcytosine.
September 1971, Journal of medicinal chemistry,
R L Tolman, and R K Robins
Megaloblastosis produced by a cytosine antagonist, 1-beta-D-arabinofuranosylcytosine.
March 1963, Blood,
R L Tolman, and R K Robins
An efficient synthesis of 1-beta-D-arabinofuranosylcytosine.
May 1976, The Journal of organic chemistry,
R L Tolman, and R K Robins
Metabolism of 1-beta-D-arabinofuranosylcytosine in L cells.
October 1965, Cancer research,
R L Tolman, and R K Robins
[Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
December 1985, Nihon Gan Chiryo Gakkai shi,
R L Tolman, and R K Robins
A convenient synthesis of arabinosylcytosine (cytosine arabinoside).
March 1967, The Journal of organic chemistry,
R L Tolman, and R K Robins
Inhibition of DNA synthesis by 1-beta-D-arabinofuranosylcytosine.
May 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
R L Tolman, and R K Robins
Occupational contact dermatitis from cytosine arabinoside synthesis.
January 1984, Contact dermatitis,
R L Tolman, and R K Robins
Chemical synthesis of DNA oligomers containing cytosine arabinoside.
October 1988, Nucleic acids research,
R L Tolman, and R K Robins
The synthesis, characterization, and preliminary biological evaluation of 1-beta-D-arabinofuranosylcytosine-5'-diphosphate-L-1,2-dipalmitin.
November 1978, Biochemical and biophysical research communications,
Copied contents to your clipboard!